Company / CapEx per Share
Revolution Medicines, Inc. CapEx per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.09
FY2025
5-year range
$0.04 / $0.09
FY2021-FY2025
Trend
+37.4%
vs FY2024
Sector context
#61 of 192
Health Care
What the data says
At $0.09, Revolution Medicines, Inc.'s capex per share ranks #61 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 8 years, ranging from $0.04 in FY2021 to $0.93 in FY2019.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of -28.3%.
Remained stable around $0.09 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +29.6%
- 5-Year CAGR
- -28.3%
- 10-Year CAGR
- -
Sector benchmark
#61 of 192 in Health CareTop 32% of 192This company $0.09 Sector average $2.46
▼
-96.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 37.4% year-over-year.
- Ranks #61 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | +37.4% |
| FY2024 | $0.06 | -26.8% |
| FY2023 | $0.09 | +116.1% |
| FY2022 | $0.04 | +1.8% |
| FY2021 | $0.04 | -91.5% |
| FY2020 | $0.46 | -51.2% |
| FY2019 | $0.93 | +43.2% |
| FY2018 | $0.65 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026